✦ LIBER ✦

EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines

✍ Scribed by Yukihiro Hiraishi; Takeshi Wada; Ken Nakatani; Itaru Tojyo; Takashi Matsumoto; Norifumi Kiga; Kenji Negoro; Shigeyuki Fujita

Book ID: 107636188
Publisher: Springer Netherlands
Year: 2008
Tongue: English
Weight: 153 KB
Volume: 14
Category: Article
ISSN: 1219-4956
DOI: 10.1007/s12253-008-9020-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR inhibitor enhances cisplatin sensit

EGFR inhibitor enhances cisplatin sensitivity of human glioma cells

✍ Yan Zhang; Xihong Xing; Hongfeng Zhan; Qiaoyu Li; Yu Fan; Liping Zhan; Qiang Yu; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 Chinese ⚖ 537 KB

Butyrate response factor 1 enhances cisp

Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines

✍ Seung Koo Lee; Seong Bum Kim; Jong Soo Kim; Chang Hoon Moon; Myung Shin Han; Byu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

Cisplatin is a widely used chemotherapeutic agent in head and neck squamous cell carcinoma (HNSCC). Resistance to cisplatin is a common feature of HNSCC. To identify genes that may regulate cisplatin sensitivity, we carried out a cDNA microarray analysis of gene expression in cisplatin-sensitive and

Immunohistochemical expression of EGFR a

Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas

✍ Yukihiro Hiraishi; Takeshi Wada; Ken Nakatani; Kenji Negoro; Shigeyuki Fujita 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 395 KB

Enhanced susceptibility of oral squamous

Enhanced susceptibility of oral squamous cell carcinoma cell lines to FAS-mediated apoptosis by cisplatin and 5-fluorouracil

✍ Masayasu Iwase; Hitoshi Watanabe; Gen Kondo; Masaru Ohashi; Masao Nagumo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB 👁 1 views

## Abstract Our study was conducted to investigate whether anticancer drugs, cisplatin (CDDP) and/or 5‐fluorouracil (5‐FU), can modulate Fas‐mediated apoptosis in oral squamous cell carcinoma (OSCC) cell lines. When OSCC cell lines, NA and HSC‐4, were treated with CDDP and/or 5‐FU, Fas and its mRNA

Cetuximab enhances the efficacy of borte

Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines

✍ Jens Wagenblast; Mehran Baghi; Christoph Arnoldner; Sotirios Bisdas; Wolfgang Gs 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 343 KB

Antitumor activity of satraplatin in cis

Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells

✍ Yukio Yamano; Masashi Shiiba; Kenji Negoro; Ken Nakatani; Atsushi Kasamatsu; Mas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

## Abstract ## __Background.__ The aim of the current study was to identify the antitumor activity of satraplatin in paired cisplatin (CDDP)‐resistant oral squamous cell carcinoma (OSCC) cell line and its parental cell line. ## __Methods.__ CDDP‐resistant (KB‐R) cells and parental cells (KB) pai